1 / 5

Depyrogenated Sterile Empty Vials Market Size, Share and Growth Report, 2030

The depyrogenated sterile empty vials market has garnered USD 3,089.8 million in 2022, and it will touch USD 4,521.7 million, propelling at a 4.9% compound annual growth rate, by 2030.

psmarket
Download Presentation

Depyrogenated Sterile Empty Vials Market Size, Share and Growth Report, 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 1 Depyrogenated Sterile Empty Vials Market Size, Share and Growth Report, 2030 1 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  2. 2 The depyrogenated sterile empty vials market will touch USD 4,521.7 million by 2030, at a rate of 4.9% by the end of this decade. This is attributed to the increasing count of clinical labs, the progression of technologies in pharma packaging, and the fast expansion of the pharma sector. Tech advances in pharma packaging are also increasing the market growth. The pharma packaging industry is incessantly developing and has experienced annual growth of as a minimum of 5% per annum in the past. Likewise, utmost packaged goods and pharmaceuticals need quick and dependable packaging for the safe product delivery, patient comfort, product protection, tampered evidence, and security requirements. Furthermore, in the next 10 years, the pharma sector will use smart packaging, more importance on sustainability, more tailored packaging, more importance on safety features, and greater usage of digital techs. These variations improve supply chain competence, advance patient safety, decrease waste, and minimalize the jeopardy of counterfeit drug. The clinical laboratories had the largest share, about 60%, in 2022 in the industry, because of the growing count of such labs. For example, India has a numerous population, over 1.4 billion, and consequently the nation has a large count of clinical labs. In the past years, the number of clinical labs in the nation has grown quickly. This is mostly because of the increasing need for medical testing services, along with the government efforts to improve access to healthcare. Likewise, the government is investing in infra and training for pathology labs, for enhancing testing quality. It is expected that with the increasing count of labs in the nation, the medical care quality will advance. North America depyrogenated sterile empty vials market had the largest share, about 40%, in 2022. This is mostly because of the increasing requirement for such vials in various research labs and clinical settings, tech advances in pharma packaging, and the growing incidence of infectious ailments. For example, Chlamydia is the most prevalent ailment in the U.S., with about 1.7 million cases in 2021. Other common infectious ailments are E. coli, Staph Herpes, and HIV. APAC will have the fastest growth in the years to come. This is mostly credited to the snowballing cases of infectious ailments as a result of the changes in rising antimicrobial resistance, human behavior and enhanced screening intensity and diagnostic techs. 2 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  3. 3 The most often happening ailments are zoster, pneumonia, and influenza. For example, in 2022, as per a study, amongst 4 million patients in China, over 0.1 million individuals were found to be affected by communicable ailments, with an incidence density of 695 per 100,000 people per year. It is because of the rise in the number of clinical labs all over the world, the demand for depyrogenated sterile empty vials is on the rise. Request PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ Click Here to Download a Sample Report Depyrogenated Sterile Empty Vials Market Segmentation By Type •2 mL •5 mL •10 mL •20 mL •More than 20 mL By End User •Clinical Labs •Compounding Labs •Pharma and Biotech Companies •Others By Region •North America Depyrogenated Sterile Empty Vials Market oBy type oBy end user oBy country – U.S. and Canada •Europe Depyrogenated Sterile Empty Vials Market oBy type oBy end user oBy country – France, Germany, Italy, Spain, U.K., and Rest of Europe •Asia-Pacific (APAC) Depyrogenated Sterile Empty Vials Market oBy type 3 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  4. 4 oBy end user oBy country – China, India, Japan, South Korea, Australia, and Rest of APAC •Latin America (LATAM) Depyrogenated Sterile Empty Vials Market oBy type oBy end user oBy country – Brazil, Mexico, and Rest of LATAM •Middle East and Africa (MEA) Depyrogenated Sterile Empty Vials Market oBy type oBy end user oBy country – Saudi Arabia, South Africa, and Rest of MEA 4 © Prescient & Strategic Intelligence Private Limited. All rights reserved

  5. 5 Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 4 ©P&SIntelligence.Allrightsreserved 5 © Prescient & Strategic Intelligence Private Limited. All rights reserved

More Related